4//SEC Filing
Karande Mahesh 4
Accession 0000899243-22-010694
CIK 0001850838other
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 4:05 PM ET
Size
5.5 KB
Accession
0000899243-22-010694
Insider Transaction Report
Form 4
Karande Mahesh
DirectorPresident and CEO10% Owner
Transactions
- Award
Option (Right to Buy)
2022-03-09+340,000→ 340,000 totalExercise: $10.34Exp: 2032-03-08→ Common Stock (340,000 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable with respect to 25% of the underlying shares on March 9, 2023 and in equal quarterly installments thereafter such that the option will become fully vested and exercisable on March 9, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Documents
Issuer
Omega Therapeutics, Inc.
CIK 0001850838
Entity typeother
Related Parties
1- filerCIK 0001860422
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 7:00 PM ET
- Accepted
- Mar 11, 4:05 PM ET
- Size
- 5.5 KB